Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
Substance Name: Phenytoin
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Can we safely target the WNT pathway?
Is natalizumab overshooting its rebound?
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Neuropsychological Aspects of Childhood Multiple Sclerosis: An Overview.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Treatment of HIV and Risk of Multiple Sclerosis.
Olfactory dysfunction in multiple sclerosis.
Pages
« first
‹ previous
…
194
195
196
197
198
199
200
201
202
…
next ›
last »